Blood glucose self-monitoring in type 2 diabetes: A randomised controlled trial

Health Technology Assessment

Volumn 13, Issue 15, 2009, Pages

  Farmer, A J ^a   Wade, A N ^b   French, D P ^c   Simon, J ^d   Yudkin, P ^a   Gray, A ^d   Craven, A ^a   Goyder, L ^e   Holman, R R ^a   Mant, D ^a   Kinmonth, A L ^f   Neil, H A W ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^c Institute for Clean Growth and Future Mobility   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ADD ON THERAPY; ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; ATTITUDE TO ILLNESS; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DIET THERAPY; DISEASE DURATION; DRUG DOSE INCREASE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH BELIEF; HEALTH CARE COST; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INTERMETHOD COMPARISON; LIFESPAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PHYSICAL ACTIVITY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF MONITORING; SELF REPORT; STATISTICAL ANALYSIS; TREATMENT OUTCOME; URINALYSIS; WELLBEING;

EID: 65349139028     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta13150     Document Type: Article

References (67)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 204;27(5):1047-53.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
3. Garfield SA, Malozowski S, Chin MH, Venkat Narayan KM, Glasgow RE, Green LW, et al. Considerations for diabetes translational research in real-world settings. Diabetes Care 2003;26(9):2670-4.
4. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 2002;25(7): 1159-71.
5. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. New Engl J Med 2005;353(25):2643-53.
6. DAFNE Study Group, Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002; 325(7367):746.
7. Blonde L, Ginsberg BH, Horn S. Frequency of blood glucose monitoring in relation to glycaemic control in patients with type 2 diabetes. Diabetes Care 2002;25(1):245-6.
8. European Diabetes Policy Group. A desktop guide to type 2 diabetes mellitus. Diabet Med 1999;16:716-30.
9. Farmer AJ, Neil A. Variations in glucose self-monitoring during oral hypoglycaemic therapy in primary care (letter). Diabet Med 2004; 22(4):511.
10. Davidson MB. Counterpoint: self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care 2005;28(6): 1531-3.
11. Owens DR, Barnett AH, Pickup J, Kerr D, Bushby P, Hicks D, et al. Blood glucose self-monitoring in type 1 and type 2 diabetes: reaching a multi-disciplinary consensus. Diabetes Prim Care 2004; 6(1):398-402.
12. American Diabetes Association. Standards of medical care in diabetes - 2006. Diabetes Care 2006;29(Suppl 1):4-42.
13. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth J, Kolb H, et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006; 49(2):271-8.
14. Davis WA, Bruce DG, Davis ME. Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study. Diabetologia 2007;50(3):510-15.
15. Karter AJ, Ackerson LM, Darbinian JA, D'Agostino RB, Ferrara A, Liu J, et al. Self-monitoring of blood glucose levels and glycaemic control: the Northern Kaiser Permanente Registry. Am J Med 2001; 111:1-9.
16. Coster S, Gulliford MC, Seed PT, Powrie JK, Swaminatham R. Self-monitoring in type 2 diabetes mellitus: a meta-analysis. Diabet Med 2000;17:755-61.
17. Halimi S. Apports de 'auto surveillance glycemique dans la prise en charge des diabetique insulino (DID) et non insulino dependents (DNID). Diabetes Metab (Paris) 1998;24(Suppl 3):35-41.
18. Faas A, Schellevis FG, van Eijk JT. The efficacy of self-monitoring of blood glucose in NIDDM subjects: a criteria-based literature review. Diabetes Care 1997;20:1482-6.
19. Schwedes U, Siebolds M, Mertes G. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 2002;25(11):1928-32.
20. Guerci B, Drouin P, Grange V, Bougneres P, Fontaine P, Kerlan V, et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003; 29(6):587-94.
21. Peel E, Parry O, Douglas M, Lawton J. Blood glucose self-monitoring in non-insulin-treated type 2 diabetes: a qualitative study of patients' perspectives. Br J Gen Pract 2004;54(500):183-8.
22. Fox MA, Cassmeyer V, Eaks GA, Hamera E, O'Connell K, Knapp T. Blood glucose self-monitoring usage and its influence on patients' perceptions of diabetes. Diabetes Educ 1984;10(3):27-31.
23. Leventhal H, Nerenz DR, Steele DJ. Illness representations and coping with health threats. In Baum A, Taylor SE, Singer JE, editors. Handbook of psychology and health. Hillsdale, NJ: Erlbaum; 1984. pp. 219-52.
24. Hampson SE, Glasgow RE, Toobert DJ. Personal models of diabetes and their relations to self-care activities. Health Psychol 1990; 9(5):632-46.
25. Hampson SE, Glasgow RE, Foster LS. Personal models of diabetes among older, adults: relationship to self-management and other variables. Diabetes Educ 1995;21(4):300-7.
26. Hampson SE, Glasgow RE, Strycker LA. Beliefs versus feelings: a comparison of personal models. and depression for predicting multiple outcomes in diabetes. Br J Health Psychol 2000;5(1):27-40.
27. Petrie KJ, Cameron S, Ellis CJ, Buick D, Weinman J. Changing illness perceptions following myocardial infarction: an early intervention randomized controlled trial. Psychosom Med 2002;64:580-6.
28. Hardeman W, Griffin S, Johnston M, Kinmonth AL, Wareham NJ. Interventions to prevent weight gain: a systematic review of psychological models and behaviour change methods. Int J Obes Relat Metab Disord 2000;24(2): 131-43.
29. Strecher VJ, Seijts GH, Kok GJ, Latham GP, Glasgow R, DeVellis B et al. Goal setting as a strategy for health behavior change. Health Educ Q 1995;22(2): 190-200.
30. Farmer A, Wade A, French DP, Goyder E, Kinmonth AL, Neil A. The DiGEM trial protocol - a randomised controlled trial to determine the effect on glycaemic control of different strategies of SMBG in people with type 2 diabetes [ISRCTN47464659]. BMC Fam Pract 2005;6:25.
31. EuroQol Group. EuroQol: a new facility for the measurement of health related quality of life. Health Pol 2001;16:199-208.
32. Evans S, Royston P, Day S. Minim: allocation by minimisation in clinical trials. 2004. URL: www-users.york.ac.uk/~mb55/guide/minim.htm. Accessed 9 December 2008.
33. National Institute for Clinical Excellence. Management of type 2 diabetes: management of blood glucose. London: National Institute for Clinical Excellence; 2002.
34. Hardeman W, Sutton S, Griffin S, Johnston M, White AJ, Wareham NJ, et al. A causal modelling approach to the development of theory-based behaviour change programmes for trial evaluation. Health Educ Res 2005;20(6):676-87.
35. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999; 281(21):2005-12.
36. Clarke PM, Gray AM, Briggs A, Farmer A, Fenn P, Stevens R et al. A model to estimate the lifetime. health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model. Diabetologia 2004;47:1747-59.
37. Royston P. Multiple imputation of missing values: update of ice. Stata J 2005;5:527-36.
38. Dolan P, Gudex C, Kind P, Williams A. A social tariff for EuroQol: results from a UK population survey. York: CHE University of York; 1995.
39. Curtis L, Netten A. Costs of health and social care 2006. Kent: PSSRU; 2006.
40. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary (BNF) 52. London: BMA/RPSGB; 2006.
41. Department of Health. Prescription cost analysis, 2005. 2007. URL: www.ic.nhs.uk/pubs/prescostanalysis2005. Accessed 3 April 2007.
42. National Health Service. Annual financial returns of NHS trusts 2003-2004. Leeds: National Health Service; 2007.
43. Netten A, Curtis L. Costs of health and social care 2002. Kent: PSSRU; 2002.
44. Department of Health. NHS reference costs 2005/06. 2007.
45. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 1997.
46. Great Britain HM Treasury. Green book, appraisal and evaluation in central government. London: Stationery Office; 2003.
47. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness, analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997;6:327-40.
48. Briggs AH, Gray AM. Handling uncertainty when performing economic evaluations of healthcare interventions. Health Technol Assess 1999;3:47-59.
49. National Institute for Health and Clinical Excellence. Social value judgements: principles for the development of NICE guidance. London: NICE; 2005.
50. Department of Health. Review body of doctors' and dentists' remuneration: review for 2004. 2004.
51. Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care 2000;23(7):943-50.
52. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 2001;47:555-67.
53. Lewis KS, Jennings AM, Ward JD, Bradley C. Health belief scales developed specifically for people with tablet-treated type 2 diabetes. Diabet Med 1990;7:148-55.
54. Riazi A, Bradley C, Barendse S, Ishii H. Development of the well-being questionnaire short-form in Japanese: the WBQ-12. Health Qual Life Outcomes 2006;4(1):40.
55. Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D. The revised illness perception questionnaire (IPQ-R). Psychol Health 2002;17:1-6.
56. Horne R. Nonadherence to medication: causes and implications for care. In Gard P, editor. A behavioural approach to pharmacy practice. Oxford: Blackwell; 2001. pp. 111-30.
57. Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from seven studies and a revised scale. Diabetes Care 2000;23:943-50.
58. Bradley C. Diabetes treatment satisfaction questionnaire (DTSQ). In Bradley C, editor. Handbook of psychology and diabetes. Switzerland: Harwood Academic Publishers; 1994, pp. 111-32.
59. Riazi A, Bradley C, Barendse S, Ishii H. Development of the well-being questionaire short-form in Japenese: the W-BQI2. Health Qual Life Outcomes 2006;4:40.
60. Wade A. Impact of self-monitoring of blood glucose in non-insulin dependant diabetes. PhD thesis. Oxford; University of Oxford;2006.
61. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51(6):1173-82.
62. Bergenstal RM, Gavin III JR. The role of self-monitoring of blood glucose inthe care of people with diabetes: report of a global consensus conference. Am J Med 2005;118(9, Suppl 1): 1-6.
63. Gerich JE. Clinicians can help their patients control postprandial hyperglycemia as a means of reducing. cardiovascular risk. Diabetes Educ 2006;32(4):513-22.
64. Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Di Nardo B, Greenfield S et al. Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control. Diabet Med 2005;22:900-6.
65. Welschen LMC, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WAB, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 2005;28(6): 1510-17.
66. Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, Ory M, et al. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol 2004;23(5):443-51.
67. Davidson MB, Castellanos M, Kain D, Duran P. The effect of self-monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 2005;118(4):422-5.